cluster in general and in HOXD9 and HOXD10 in particular (15, (21) (22) (23) . Together, these findings suggest that the HOXD cluster might have played a key role in the recent evolution of human limbs.
Enhancers are often deoxyribonuclease I (DNase I)-sensitive regions bound by p300 and histone variant H2A.Z and marked by the histone modifications H3K4me1 and H3K27ac (24, 25) . For insulators, CCCTC binding factor (CTCF) plays a major role as a buffer between active and inactive regions. By using a randomization test, we found a significant enrichment for enhancer marks and for CTCF binding in the intergenic DMRs, with over 80% having these marks (Fig.  3C, fig. S5 , and tables S2 and S4). We show that this cannot be explained by length, CG-content, CpG density, or coverage (7) . This suggests that many of the intergenic DMRs may affect gene activity through distal elements. Additionally, both of the intergenic DMRs upstream of the HOXD cluster possess enhancer marks (table S2), suggesting that they might have affected the methylation of the HOXD cluster through distal regulation.
DNA methylation affects, as well as is affected by, the binding of transcription factors (TFs) (3, 4) . To test whether multiple DMRs may be associated with a change in a single TF, we looked for TF-encoding genes that are differentially methylated and whose targets are enriched with DMRs (7) (tables S5 and S6). In the Neandertal, we identified sterol regulatory element binding protein 1 (SREBP-1), a regulator of lipid homeostasis (F DR ¼ 5:5 Â 10 −3 ; Fisher's exact test), and aryl hydrocarbon receptor (AHR), a receptor of environmental toxins (FDR ¼ 3:7 Â 10 −8 ). In present-day humans, we identified early growth response 3 (EGR3), which regulates biorhythm and development of muscles, lymphocytes, and neurons (FDR ¼ 4:2 Â 10 −10 ); and Meis homeobox 1 (MEIS1), a regulator of limb development that forms complexes with both HOXD9 and HOXD10 (F DR ¼ 5:6 Â 10 −8 ). This enrichment is independent of CpG density, GC content, and coverage (7) . Additionally, the number of TFs that passed this test is significantly higher than would be expected by random (P = 0.018, hypergeometric test). These TFs could provide a lead to the mechanism behind the methylation changes and possibly offer a model of burstlike evolution, where multiple genes changed their activity after a single evolutionary event.
Last, we found that DMR-containing genes in present-day humans are almost twice as likely as genes that do not contain DMRs to be diseaserelated (18.1% compared with 10.8%, P =1.9 × 10 −7 , Fisher's exact test) (fig. S6 and table S7 ). More than a third of the disease-linked genes (30/81) are involved in neurological and psychiatric disorders. Here, too, the enrichment is independent of gene length, CpG density, GC content, and coverage (7) . This could potentially point to a link between recent changes in regulation and the emergence of diseases or to a scenario where disease-linked genes (i.e., genes in which a change is not embryonic lethal) are possibly more prone to methylation changes.
Current techniques for measuring genomewide methylation result in the destruction of the examined DNA (3) and are therefore impracticable in the study of ancient DNA. Our method allows for the reconstruction of methylation maps directly from ancient DNA reads without the need to use additional ancient material. We hope that the differences in methylation elucidated here will help to uncover the epigenetic basis for phenotypic differences between presentday and archaic humans and shed light on the role of epigenetics in the recent evolution of our lineage. expression, DNA replication, or DNA repair. Improving nuclear architecture of laminopathic cells can ameliorate defects in chromatin structure and other processes, thus improving some disease phenotypes (8, 9) .
Lamin A/C depletion by small interfering RNA (siRNA) transfection (siLMNA) caused nuclearshape defects (Fig. 1, A and B, and fig. S1 , A and B), global chromatin relaxation, and increased nuclear area (fig. S1, C and D). We therefore reasoned that modulating chromatin organization by lysine acetyltransferase (KAT) or lysine deacetylase (KDAC) inhibition might improve nuclear architecture defects of siLMNA cells. Compound screening identified the KAT inhibitor 4-(4-chlorophenyl)-2-(2-cyclopentylidenehydrazinyl) thiazole (1) (Fig. 1C) , which restored nuclear circularity and global chromatin compaction in siLMNA cells (Fig. 1, D and E, and fig. S1 , E to G). Although molecule 1 was identified in Saccharomyces cerevisiae as a GCN5 (general control of amino acid synthesis protein 5-like 2) network inhibitor (10), nuclear shape rescue was GCN5-independent because the benchmark GCN5 inhibitor MB-3 had no effect on nuclear circularity. Complete nuclear-shape rescue by molecule 1 occurred within 12 hours of treatment (Fig. 1F) , independently of mitosis ( fig. S2A and movie S1) and without markedly affecting the cell cycle ( fig. S2, B and C) . Moreover, compound 1 improved the nuclear morphology of several cancer cell lines displaying reduced lamin A/C expression (fig. S2, D and E), indicating that its effects were not specific to siRNA-mediated lamin A/C depletion. To identify putative targets of 1, we synthesized a "clickable" cell-active analog 2 and used inactive molecule 3 as a negative control (Fig. 1, G and H) . We then used "click-chemistry" to retrieve and validate drug-associated proteins. The alkyne moiety selectively reacts with an azide group upon copper exposure, allowing tagging of the clickable molecules in cells (Fig. 1I) . First, we incubated a biotinylated derivative of 2 in cell extracts ( fig. S3A ), retrieved associated proteins with streptavidin beads, and identified several protein species whose staining intensities were reduced by an excess of competitor 1 ( fig.  S2B) . These proteins were then identified by means of liquid chromatography-mass spectrometry (LC-MS)/MS ( fig. S2C ). N-acetyltransferase 10 (NAT10) was the only KAT protein identified, thus being the only likely relevant target of 1.
NAT10 was previously linked with the SUN1 nuclear envelope protein (11) , whose depletion rescues nuclear shape in cells in which LMNA had been knocked out (8) , and NAT10 KAT activity has been demonstrated toward microtubules and histones (12) .
Preincubating clickable molecules with live cells followed by click pull-down identified NAT10 as a specific target of 2 in vivo (Fig. 1J) , establishing our protocol as a framework for identifying specific partners without photo-cross-linking agents (13) . In parallel, we visualized subcellular localizations of clickable molecules by means of fluorescence microscopy ( Fig. 1K) (14) . This revealed that 2 specifically accumulated in nucleoli and also localized at the nuclear periphery and in the cytoplasm (Fig. 1K and fig. S4A ) (Fig. 1K) without changes in nucleolar architecture [NAT10 localization was not affected by treatment with 1 or siLMNA ( fig. S4C)] . Furthermore, we established direct physical interaction between 1 and NAT10 using circular dichroism spectroscopy ( fig. S4D ). Because molecule 1 was rapidly degraded upon light and air exposure, we explored its structural derivatives for their ability to rescue nuclear shape of siLMNA cells (fig. S5A) . The most potent and stable analog identified (4) ( fig. S5B ) was named "Remodelin" on the basis of its ability to remodel nuclear architecture of siLMNA cells (Fig. 1L) . Consistent with a model in which Remodelin affects siLMNA cells through NAT10 targeting, we found that NAT10 depletion ( Fig. 2A) corrected the aberrant nuclear morphology of siLMNA cells (Fig. 2B) . Because 1, the analog of Remodelin, was identified as a KAT inhibitor, we assessed whether Remodelin affected NAT10 KAT activity. Aligning human NAT10 with the three-dimensional (3D) structure of its bacterial homolog in complex with acetyl-coenzyme A (acetyl-CoA) (15) led us to mutate conserved glycine-641 to glutamate (G641E), which was predicted to impair acetyl-CoA binding (Fig. 2,  C and D, and fig. S6A ). Indeed, this mutation blocked NAT10 activity (Fig. 2E and fig. S6B ). Moreover, wild-type NAT10 activity was inhibited by Remodelin or clickable molecule 2, establishing Remodelin as a bona fide NAT10 inhibitor. Complementation assays with siRNAresistant wild-type (NAT10 WT) or G641E mutant NAT10 (NAT10 MUT) ( fig. S6, C and D) showed that rescue of nuclear circularity in siLMNA cells required loss of NAT10 catalytic function (Fig. 2F) . Thus, inactivating NAT10 KAT activity through mutation or with Remodelin restores normal nuclear morphology in siLMNA cells.
We next investigated the effects of Remodelin on cells derived from LMNA-mutated HGPS patients (AG11498 and AG06297). HGPS cells accumulate Progerin, a permanently farnesylated, truncated form of lamin A, leading to nuclear membrane folding and nuclear blebbing (Fig. 3A) that contribute to the premature-aging phenotypes of HGPS patients. Remodelin markedly reduced the prevalence of misshapen nuclei in HGPS cells (Fig. 3B) as well as in primary MRC5 fibroblasts aged in culture ( fig. S7, A and B) , which also accumulate Progerin upon extended passaging (16) S7, C and D) . Farnesyltransferase inhibitors (FTIs) prevent accumulation of farnesylated Progerin at the nuclear membrane, thus reducing HGPS nuclear blebbing (17) . Unlike FTIs, however, Remodelin did not trigger pre-lamin A accumulation ( fig. S8A ), indicating that 
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Remodelin is not an FTI. However, Remodelin and FTI did not act synergistically on nuclear shape improvement, suggesting that they affect a common pathway ( fig. S8, B and C) . Unlike Remodelin, FTI did not improve nuclear morphology in siLMNA cells. Furthermore, although FTI improves HGPS nuclear shape, it had the opposite effect on Progerin-negative cells ( fig.  S8 , B and C), probably by causing accumulation of unprocessed lamin A and B and centrosome separation defects (18) (19) (20) . In contrast, Remodelin prevented FTI-induced nuclear shape defects in normal fibroblasts and U2OS cells ( fig. S8, B to D) . The proportion of misshapen nuclei in HGPS cells was similarly decreased by Remodelin treatment or NAT10 depletion (Fig. 3C and fig. S9A ), implying that NAT10 inhibition by Remodelin mediates nuclear shape normalization in HGPS cells.
Although nuclear shape improvement is not always associated with overall amelioration of HGPS cell phenotypes (21) , Remodelin improved global HGPS-cell fitness as observed by decreased steady-state levels of the DNA double-strand break markers gH2AX and autophosphorylated ATM (ataxia telangiectasia mutated), decreased DNA damage signaling (Fig. 3D and fig. S9 , B to D), improved chromatin and nucleolar organization (assessed with histone H3K9me3 and NAT10 staining), and decreased SUN1 accumulation at the nuclear envelope ( fig. S9 , E to G). Blocking DNA damage signaling by inhibiting the apical DNAdamage response kinases ATM and ATR (ataxia telangiectasia and Rad3-related) decreased gH2AX (Fig. 3, E and F) . However, unlike Remodelinwhich improved DNA replication ( fig. S9H) , enhanced cell proliferation capacity (Fig. 3G) , and decreased senescence (Fig. 3H) [other KAT inhibitors did not decrease senescence ( fig. S9I) ]-inhibiting ATM and ATR decreased proliferation and induced senescence (Fig. 3, G and H) . Similar effects were observed upon p53-pathway inhibition ( fig. S9I) . Thus, Remodelin appears to reduce the amount of DNA damage in HGPS cells, whereas damage is still present but no longer signaled properly upon ATM/ATR inhibition, leading to cell growth arrest and senescence. Moreover, Remodelin conferred long-term benefits to HGPS cells, as seen by it decreasing senescence even after several weeks of treatment (Fig. 3I) .
NAT10 localizes mainly in the nucleolus, which has a known role in maintaining nuclear shape (22, 23) . For example, depleting the nucleolar protein NPM1 changes microtubule stability (24) and affects nuclear shape via connections between the cytoskeleton and nuclear envelope. Because tubulin is a known NAT10 substrate, we examined the microtubule network and observed network reorganization upon Remodelin treatment, NAT10 depletion, or mutational inactivation of NAT10 (Fig. 4A ). In accord with there being a functional link between microtubule reorganization and nuclear shape rescue by NAT10 inhibition, the microtubule-destabilizing drugs nocodazole and colchicine also rescued the nuclear shape defects of siLMNA cells (Fig. 4B)  and HGPS cells (fig. S10A) , whereas latrunculin A, an actin polymerization inhibitor, increased nuclear distortion. Remodelin effects were not linked to Golgi apparatus fragmentation or tubulin depolymerization because in contrast to nocodazole or colchicine, Remodelin did not affect Golgi apparatus integrity or tubulin polymer assembly (Fig. 4, C and D) and did not cause cells to accumulate in mitosis.
To gain insight into how NAT10 modifies microtubule organization, we analyzed microtubule regrowth dynamics. Whereas initial microtubule regrowth (nucleation phase) appeared normal after NAT10 inhibition in siLMNA cells [ Fig. 4E , time (t) = 5 min] and HGPS cells ( fig.  S10C ), microtubule anchorage to centrosomes was affected by Remodelin in both siLMNA cells (Fig. 4E) and HGPS cells (fig. S10B ) or by the NAT10 G641E mutation (Fig. 4E, t = 15 min) , indicating that NAT10 KAT activity promotes microtubule anchorage. These results suggest that inhibiting NAT10 KAT activity in laminopathic cells reduces microtubule anchorage, releasing an external force on the nuclear envelope, thus contributing to nuclear shape rescue and global enhancement of cellular fitness ( fig. S11 ). This is in line with studies showing that releasing microtubule forces on the nucleus by growing them on a "soft" substrate normalizes the nuclear shape of laminopathic cells (25) and helps explain why Remodelin, like other microtubule-reorganizing agents (26) , corrects FTI-induced nuclear shape defects in nonprogeric cells ( fig. S8 ).
Here, we have shown that the small molecule Remodelin improves nuclear shape and fitness of both progeric and lamin A/C-depleted cells via inhibiting NAT10. Although these effects appear to be connected to NAT10 organizing the microtubule network, we cannot rule out that inhibiting additional nuclear functions of NAT10, related to chromatin, might also contribute to global improvement of cellular fitness. Small-molecule inhibitors of NAT10 may thus provide additional ways to study laminopathy-associated processes with spatial and temporal resolution, as well as opportunities for alleviating dystrophic and premature-aging diseases.
